|
|
 |
Registry of Lobbyists - Lee Swift
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 2386 | Active | | | Initial registration date | Last date of any changes | | 8-October-2021 | 5-April-2024 |
|
Lobbyist's Last Name
Swift |
Lobbyist's First Name
Lee |
Middle Initial
|
|
Business Address of Lobbyist
16750 Trans Canada Highway |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
604 220 4822 |
Fax
514 428 4955 |
| |
Business or Firm Name for Lobbyist (if applicable)
Merck Canada Inc |
Registry of Joint Stock Companies Number
3278688 |
Business Address of Lobbyist's Business or Firm
16750 Trans Canada Highway |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
514 428 7920 |
Fax
514 428 4955 |
|
| Beneficiary Name |
Beneficiary Type |
|
| Merck & Co., Inc. |
Parent Company |
View
|
|
|
|
|
Description of Employer's Business:
For more than 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada |
| |
|
|
|
| Description |
|
| Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in Nova Scotia, including under the Nova Scotia Pharmacare Programs and the Nova Scotia Drug Formulary or under federal legislation. More specifically, representations are made to support a favourable and knowledgeable environment to implement new or improve current immunizations programs, the integrations of drugs into the Nova Scotia Pharmacare Programs and the Nova Scotia Drug Formulary and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Merck Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs and vaccines, which are the company’s main sectors of activities. |
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
